Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia

✍ Scribed by Elhilali, Mostafa M.; Pommerville, Peter; Yocum, Richard C.; Merchant, Rosemina; Roehrborn, Claus G.; Denmeade, Samuel R.

• Book ID: 123093763
• Publisher: Lippincott Williams and Wilkins
• Year: 2013
• Tongue: English
• Weight: 811 KB
• Volume: 189
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2012.11.003